Literature DB >> 19843937

Functional expression of formyl peptide receptor family in human NK cells.

Sang Doo Kim1, Jung Mo Kim, Seong Ho Jo, Ha Young Lee, Sun Young Lee, Jae Woong Shim, Su-Kil Seo, Jeanho Yun, Yoe-Sik Bae.   

Abstract

We determined the expression of the formyl peptide receptor (FPR) family and the functional roles of the FPR family in NK cells. All tested human NK cells express two members of the FPR family (FPR1 and FPR2). The expression of FPR3 was noted to occur in a donor-specific manner. The stimulation of NK cells with FPR family-selective agonists (fMLF (N-formyl-Met-Leu-Phe), MMK-1, F2L, and WKYMVm (Trp-Lys-Tyr-Met-Val-d-Met)) elicited cytolytic activity in resting NK cells, but not in IL-2-activated NK cells; the cytolytic activity was not inhibited by pertussis toxin. The FPR family agonists also stimulated chemotactic migration of IL-2-activated NK cells, but not resting NK cells; the chemotactic migration was completely inhibited by pertussis toxin. WKYMVm stimulates ERK, p38 MAPK, and JNK activities in both resting and IL-2-activated NK cells. WKYMVm-induced chemotactic migration was partially inhibited by PD98059 (2'-amino-3'-methoxyflavone); however, the inhibition of JNK by its selective inhibitor (SP600125, anthra[1,9-cd]pyrazol-6(2H)-one) dramatically inhibited the WKYMVm-induced cytolytic activity. Furthermore, WKYMVm-induced chemotactic migration and cytolytic activity were partly inhibited by FPR family-selective antagonists (cyclosporin H and WRWWWW). Taken together, our findings indicate that human NK cells express functional members of the FPR family, and in turn the activation of the three members of the FPR receptor family elicit cytolytic activity in NK cells, thus suggesting that the receptors are potentially important therapeutic targets for the modulation of NK cell-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843937     DOI: 10.4049/jimmunol.0802986

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells.

Authors:  Liang Zhang; Huanyu Wang; Tianshu Yang; Zhifeng Su; Dan Fang; Yafeng Wang; Jiazhu Fang; Xinwei Hou; Yingying Le; Keqiang Chen; Ji Ming Wang; Shao Bo Su; Qing Lin; Qi Zhou
Journal:  Oncoimmunology       Date:  2015-08-24       Impact factor: 8.110

2.  4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.

Authors:  Liliya N Kirpotina; Igor A Schepetkin; Andrei I Khlebnikov; Olga I Ruban; Yunjun Ge; Richard D Ye; Douglas J Kominsky; Mark T Quinn
Journal:  Biochem Pharmacol       Date:  2017-07-08       Impact factor: 5.858

3.  Formyl peptide receptor suppresses melanoma development and promotes NK cell migration.

Authors:  Jian Liu; Jun Li; Xiang Zeng; Zhiguo Rao; Jianfei Gao; Bicheng Zhang; Yong Zhao; Bo Yang; Zhigang Wang; Lifang Yu; Weixing Wang
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

Review 4.  New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery.

Authors:  Julia Park; Christopher J Langmead; Darren M Riddy
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-20

5.  The leukocyte chemotactic receptor FPR1 is functionally expressed on human lens epithelial cells.

Authors:  Erich H Schneider; Joseph D Weaver; Sonia S Gaur; Brajendra K Tripathi; Algirdas J Jesaitis; Peggy S Zelenka; Ji-Liang Gao; Philip M Murphy
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

Review 6.  Regulation of inflammation by members of the formyl-peptide receptor family.

Authors:  Keqiang Chen; Zhiyao Bao; Wanghua Gong; Peng Tang; Teizo Yoshimura; Ji Ming Wang
Journal:  J Autoimmun       Date:  2017-07-06       Impact factor: 7.094

7.  Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.

Authors:  Walid S Maaty; Connie I Lord; Jeannie M Gripentrog; Marcia Riesselman; Gal Keren-Aviram; Ting Liu; Edward A Dratz; Brian Bothner; Algirdas J Jesaitis
Journal:  J Biol Chem       Date:  2013-07-19       Impact factor: 5.157

8.  Biomedical therapy using synthetic WKYMVm hexapeptide.

Authors:  Young Hwan Choi; Il Ho Jang; Soon Chul Heo; Jae Ho Kim; Nathaniel S Hwang
Journal:  Organogenesis       Date:  2016-04-14       Impact factor: 2.500

9.  HCV peptide (C5A), an amphipathic α-helical peptide of hepatitis virus C, is an activator of N-formyl peptide receptor in human phagocytes.

Authors:  Qing Lin; Dan Fang; Xinwei Hou; Yingying Le; Jiazhu Fang; Feng Wen; Wanghua Gong; Keqiang Chen; Ji Ming Wang; Shao Bo Su
Journal:  J Immunol       Date:  2011-01-12       Impact factor: 5.422

Review 10.  The N-Formyl Peptide Receptors and Rheumatoid Arthritis: A Dangerous Liaison or Confusing Relationship?

Authors:  Ilaria Mormile; Francesca Wanda Rossi; Nella Prevete; Francescopaolo Granata; Valentina Pucino; Amato de Paulis
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.